Cargando…

P04-26. Immunological tolerance prevents the expression of a broadly reactive neutralizing HIV-1 antibody

Detalles Bibliográficos
Autores principales:	Verkoczy, L, Diaz, M, Holl, TM, Ouyang, Y, Bouton-Verville, H, Alam, SM, Liao, H, Kelsoe, G, Haynes, BF
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767956/ http://dx.doi.org/10.1186/1742-4690-6-S3-P54

Ejemplares similares

P04-44. Generation of antibody responses to HIV-1 membrane proximal external region (MPER) antigen
por: Holl, TM, et al.
Publicado: (2009)

Immune System Regulation in the Induction of Broadly Neutralizing HIV-1 Antibodies
por: Kelsoe, Garnett, et al.
Publicado: (2013)

HIV-1 Envelope gp41 Broadly Neutralizing Antibodies: Hurdles for Vaccine Development
por: Verkoczy, Laurent, et al.
Publicado: (2014)

Functional, Non-Clonal IgM(a)-Restricted B Cell Receptor Interactions with the HIV-1 Envelope gp41 Membrane Proximal External Region
por: Verkoczy, Laurent, et al.
Publicado: (2009)

P04-48. HIV-1 envelope induces memory B cell responses that correlate with plasma antibody levels after gp120 protein vaccination or chronic HIV-1 infection
por: Bonsignori, M, et al.
Publicado: (2009)

OA021-04. HIV-1 gp41 envelope MPER mutation altered epitope conformation in lipid and increased sensitivity to 2F5 and 4E10 neutralizing antibodies
por: Shen, X, et al.
Publicado: (2009)

Identification of autoantigens recognized by the 2F5 and 4E10 broadly neutralizing HIV-1 antibodies
por: Yang, Guang, et al.
Publicado: (2013)

Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies
por: Haynes, Barton F., et al.
Publicado: (2022)

Strategies for induction of HIV‐1 envelope‐reactive broadly neutralizing antibodies
por: Williams, Wilton B., et al.
Publicado: (2021)

Autoreactivity and broad neutralization of antibodies against HIV-1 are governed by distinct mutations: Implications for vaccine design strategies
por: Li, Xiaojun, et al.
Publicado: (2022)

Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies
por: Bajic, Goran, et al.
Publicado: (2019)

Cross-reactive broadly neutralizing antibodies: timing is everything
por: Euler, Zelda, et al.
Publicado: (2012)

P04-15. Prevalence of broadly neutralizing antibody responses during acute/early HIV infection
por: Mikell, I, et al.
Publicado: (2009)

Antibody lineages with evidence of somatic hypermutation persisting for >4 years in a South African subject with broad neutralizing activity
por: Moody, M, et al.
Publicado: (2012)

P04-29. HIV-1 neutralizing antibodies inhibit plasmacytoid dendritic cells infection
por: Lederle, A, et al.
Publicado: (2009)

P04-54 LB. Genetic signature analysis identifies the CD4i region of gp120 as a determinant of broadly NAb responses in HIV-1-infected individuals
por: Gnanakaran, G, et al.
Publicado: (2009)

Cross-reactivity of glycan-reactive HIV-1 broadly neutralizing antibodies with parasite glycans
por: Huettner, Isabella, et al.
Publicado: (2022)

Immunologic characteristics of HIV‐infected individuals who make broadly neutralizing antibodies
por: Borrow, Persephone, et al.
Publicado: (2017)

P04-46. Broadly cross-neutralizing activity in plasma of HIV-1 and HIV-2 infected individuals
por: Fenyö, E, et al.
Publicado: (2009)

Progress with induction of HIV broadly neutralizing antibodies in the Duke Consortia for HIV/AIDS Vaccine Development
por: Haynes, Barton F., et al.
Publicado: (2023)

Identifying immunologically-vulnerable regions of the HCV E2 glycoprotein and broadly neutralizing antibodies that target them
por: Quadeer, Ahmed A., et al.
Publicado: (2019)

Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
por: Liao, Hua-Xin, et al.
Publicado: (2013)

P04-43. Neutralizing antibody responses against conformational envelope epitopes in early HIV-1 infection
por: Bar, KJ, et al.
Publicado: (2009)

Immunologic Basis for Long HCDR3s in Broadly Neutralizing Antibodies Against HIV-1
por: Yu, Lei, et al.
Publicado: (2014)

Affinity maturation pathway of an anti-MPER neutralizing mAb, CAP206-CH12
por: Tumba, NL, et al.
Publicado: (2012)

P15-04. Development and implementation of an international proficiency testing program for a neutralizing antibody assay for HIV-1 in TZM-bl cells
por: Todd, CA, et al.
Publicado: (2009)

Isolation of a clonal lineage of IgA broadly neutralizing antibodies from a chronically infected Tanzanian subject
por: Moody, M, et al.
Publicado: (2012)

P04-06. Evolution of an anti-MPER gp41 antibody response that mediates broad HIV-1 cross-neutralization
por: Gray, E, et al.
Publicado: (2009)

P04-51 LB. The epitopes of two newly identified broad and potent neutralizing antibodies, PG9 and PG16
por: Walker, L, et al.
Publicado: (2009)

Functional Relevance of Improbable Antibody Mutations for HIV Broadly Neutralizing Antibody Development
por: Wiehe, Kevin, et al.
Publicado: (2018)

P04-53 LB. Potent and broad HIV-specific neutralizing antibodies in infants are not associated with prevention of mother to infant HIV transmission
por: Lynch, J, et al.
Publicado: (2009)

Broadly Neutralizing Antibodies for HIV Eradication
por: Stephenson, Kathryn E., et al.
Publicado: (2016)

Initiation of HIV neutralizing B cell lineages with sequential envelope immunizations
por: Williams, Wilton B., et al.
Publicado: (2017)

S021-04 OA. A large-scale analysis of immunoglobulin sequences derived from plasmablasts/plasma cells in acute HIV-1 infection subjects
por: Munshaw, S, et al.
Publicado: (2009)

P04-04. The specific phospholipid binding and neutralizing activities of the anti-HIV antibody 4E10 are separable
por: Xu, H, et al.
Publicado: (2009)

Neutralization of Japanese Encephalitis Virus by heme-induced broadly reactive human monoclonal antibody
por: Gupta, Nimesh, et al.
Publicado: (2015)

P04-55 LB. Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypes
por: Zolla-Pazner, S, et al.
Publicado: (2009)

P04-01. Simultaneous enumeration of HIV-1 gp41 Env-specific IgG and IgM antibody-secreting cells with a multiplex B-cell fluorospot assay
por: Bonsignori, M, et al.
Publicado: (2009)

P04-27. Monoclonal neutralizing antibodies inhibit HIV-1 transfer from immature dendritic cells to human primary CD4 T-lymphocytes
por: Xu, K, et al.
Publicado: (2009)

Epitope characterization of the protective monoclonal antibody VN04-2 shows broadly neutralizing activity against highly pathogenic H5N1
por: Lim, Angeline PC, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_kuikn61s6mnl8tbc20ejpl5is6